ISRCTN16732324已完成未知
Optimised inhalers to reduce chronic obstructive pulmonary disease exacerbation re-admissions and mortality: a feasibility study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38444664/ (added 19/07/2024)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. In hospital with an exacerbation of COPD
- •2. Age 18 years or over
- •3. Able to provide informed consent
排除标准
- •Discharge home with palliative care
研究者
相似试验
已完成
4 期
Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)CHRONIC OBSTRUCTIVE PULMONARY DISEASEHEALTHY SUBJECTSASTHMANCT01721291Imperial College London64
招募中
不适用
Assessing Optimal Inhaler Strategies During Acute Exacerbations of COPD (AECOPDs) Using OscillometryCOPDCOPD Exacerbation AcuteNCT06495047McGill University Health Centre/Research Institute of the McGill University Health Centre43
已完成
不适用
Improving completion of pulmonary rehabilitation with PR-buddies (IMPROVE)Chronic obstructive pulmonary diseaseRespiratoryISRCTN12658458King's College London1,577
已完成
2 期
Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)NCT00558285Novartis257
已完成
不适用
Intervention to Reduce Misused Inhaler and Insufficient Peak Inspiratory Flow in Hospitalized COPD PatientsCOPDNCT05207631Hôpital Fribourgeois101